Prophylactic ceftizoxime for elective cesarean delivery at Soba Hospital, Sudan

Bashier Osman, Amna Abbas, Mohamed A Ahmed, Magid S Abubaker, Ishag Adam, Bashier Osman, Amna Abbas, Mohamed A Ahmed, Magid S Abubaker, Ishag Adam

Abstract

Background: A prophylactic antibiotic is recommended to reduce infection-related complication following cesarean delivery. There is a current debate on the time of prophylactic antibiotic in cesarean delivery.

Methods: An opened randomized, controlled clinical trial was conducted at Soba hospital, Sudan to investigate the timing (pre-incision or after clamping of the umbilical cord) of ceftizoxime for elective cesarean delivery. The outcome measures were; the incidence of post-cesarean febrile and infection-related morbidity and neonatal outcomes between the two groups.

Results: Hundred -eighty women (90 women in each arm of the study) received intravenous injection of 1 g of ceftizoxime as single dose either at pre-incision or after clamping of the umbilical cord. None of the women in either group had endometritis. One woman in the pre-incision group had chest infection. There was no significant difference in the incidence of wound infection between the two groups, 8 (6.7%) vs. 3 (3.3%); P = 0.2. Two babies in the pre-incision group (P = 0.497) had a low Apgar score (< 8) at 1 min. Similar number of neonate (15 in each arm) was admitted to nursery. There were no significant difference in the neonatal jaundice between the two groups, 5 (5.5%) vs. 4 (4.4%), P = 0.2. There was no perinatal death.

Conclusions: There was no difference in the two regimens (pre-incision or post-clamping of the umbilical cord) of ceftizoxime as prophylactic for elective cesarean delivery.

Trial registration: NCT01347593.

References

    1. DeFrances CJ, Cullen KA, Kozak LJ. National Hospital Discharge Survey: 2005 annual summary with detailed diagnosis and procedure data. Vital Health Stat. 2007;13:1–209.
    1. Gibbs RS. Clinical risk factors for puerperal infection. Obstet Gynecol. 1980;55(Suppl 5):178S–184S.
    1. Bagratee JS, Moodley J, Kleinschmidt I, Zawilski W. A randomized controlled trial of antibiotic prophylaxis in elective caesarean delivery. BJOG. 2001;108:143–148.
    1. Hofmeyr GJ, Smaill FM. Antibiotic prophylaxis for cesarean section. Cochrane Database Syst Rev. 2010. p. CD000933.
    1. Smaill FM, Gyte GM. Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane Database Syst Rev. 2010. p. CD007482.
    1. Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med. 1992;326:281–286. doi: 10.1002/14651858.CD007482.pub2.
    1. Smaill F, Hofmeyr GJ. Antibiotic prophylaxis for cesarean section. Cochrane Database Syst Rev. 2002. p. CD000933.
    1. Tita AT, Rouse DJ, Blackwell S, Saade GR, Spong CY, Andrews WW. Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review. Obstet Gynecol. 2009;113:675–682.
    1. American College of Obstetricians and Gynecologists. ACOG practice bulletin number 47, October 2003: Prophylactic Antibiotics in Labor and Delivery. Obstet Gynecol. 2003;102(4):875–882.
    1. Hopkins L, Smaill F. WITHDRAWN: Antibiotic prophylaxis regimens and drugs for cesarean section. Cochrane Database Syst Rev. 2012. p. CD001136.
    1. Aldridge KE. Comparison of the post-antibiotic effect (PAE) induced by ceftizoxime, ceftriaxone, cefoxitin, ampicillin-sulbactam, and ticarcillin-clavulanate against selected isolates of Bacteroides fragilis and B. thetaiotaomicron. Anaerobe. 2002;8(6):295–299. doi: 10.1016/S1075-9964(03)00024-6.
    1. Ahmed ET, Mirghani OA, Gerais AS, Adam I. Ceftriaxone versus ampicillin/cloxacillin as antibiotic prophylaxis in elective caesarean section. East Mediterr Health J. 2004;10:277–288.
    1. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definition of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992;13:606–608. doi: 10.1086/646436.
    1. Doss AE, Davidson JD, Cliver SP, Wetta LA, Andrews WW, Tita AT. Antibiotic prophylaxis for cesarean delivery: survey of maternal-fetal medicine physicians in the U.S. J Matern Fetal Neonatal Med. online.
    1. Cunningham FG, Leveno KJ, DePalma RT, Roark M, Rosenfeld CR. Perioperative antimicrobials for cesarean delivery: before or after cord clamping? Obstet Gynecol. 1983;62(2):151–154.
    1. Gordon HR, Phelps D, Blanchard K. Prophylactic cesarean section antibiotics: maternal and neonatal morbidity before or after cord clamping. Obstet Gynecol. 1979;53(2):151–156.
    1. Kaimal AJ, Zlatnik MG, Cheng YW, Thiet MP, Connatty E, Creedy P, Caughey AB. Effect of a change in policy regarding the timing of prophylactic antibiotics on the rate of postcesarean delivery surgical-site infections. Am J Obstet Gynecol. 2008;199(3):310. e1-5.
    1. Owens SM, Brozanski BS, Meyn LA, Wiesenfeld HC. Antimicrobial prophylaxis for cesarean delivery before skin incision. Obstet Gynecol. 2009;114:573–579. doi: 10.1097/AOG.0b013e3181b490f1.
    1. Yildirim G, Gungorduk K, Guven HZ, Aslan H, Celikkol O, Sudolmus S, Ceylan Y. When should we perform prophylactic antibiotics in elective cesarean cases? Arch Gynecol Obstet. 2009;280:13–18. doi: 10.1007/s00404-008-0845-7.
    1. Yokoe DS, Christiansen CL, Johnson R, Sands KE, Livingston J, Shtatland ES, Platt R. Epidemiology of and surveillance for postpartum infections. Emerg Infect Dis. 2001;7:837–841.
    1. Mitt P, Lang K, Peri A, Maimets M. Surgical-site infections following cesarean section in an Estonian university hospital: postdischarge surveillance and analysis of risk factors. Infect Control Hosp Epidemiol. 2005;26:449–454. doi: 10.1086/502566.
    1. Couto RC, Pedrosa TM, Nogueira JM, Gomes DL, Neto MF, Rezende NA. Post-discharge surveillance and infection rates in obstetric patients. Int J Gynaecol Obstet. 1998;61:227–231. doi: 10.1016/S0020-7292(98)00047-2.
    1. OpenEpio-epidemioligic calculator. .

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться